Literature DB >> 31595563

Long noncoding RNA (MEG3) in urinal exosomes functions as a biomarker for the diagnosis of Hunner-type interstitial cystitis (HIC).

Fei Liu1,2, Yuedong Chen2, Rongfu Liu2, Bin Chen2, Chunxiao Liu1, Jinchun Xing2.   

Abstract

BACKGROUND: Toll-like receptor-7 (TLR7) is functionally involved in the pathogenesis of Hunner-type interstitial cystitis (HIC). In addition, maternally expressed gene 3 (MEG3) is implicated in many urethral diseases. In this study, we aimed to verify the hypothesis that exosomal MEG3 in urine can be used as a novel diagnostic biomarker for HIC.
METHODS: Electron microscopy was utilized to observe the distribution of urinary exosomes between the case group and the control group. Receiver operating characteristic analysis was utilized to compare the diagnostic values of MEG3 and miR-19a-3p. Computational analysis and luciferase assay were conducted to identify the correlation between MEG3 and miR-19a-3p as well as between TLR7 and miR-19a-3p. In addition, real-time polymerase chain reaction and Western blot were performed to establish the signaling pathways implicated in the pathogenesis of HIC.
RESULTS: When age and gender distributions are excluded, urinary exosomes were equally distributed between case and control groups. The area under the curve of MEG3 was larger than that of miR-19a-3p, indicating that MEG3 has a better value in the diagnosis of HIC. In addition, patients with HIC showed elevated MEG3 expression and inhibited miR-19a-3p expression, thus establishing a negative correlation between MEG3 and miR-19a-3p. MEG3 and TLR7 were both identified as targets of miR-19a-3p, establishing a MEG3/miR-19a-3p/TLR7 signaling pathway, in which MEG3 enhances the expression of TLR7 via inhibiting the expression of miR-19a-3p.
CONCLUSION: MEG3 level was upregulated in patients with HIC. In addition, MEG3 downregulated miR-19a-3p expression while upregulating TLR7 expression. Furthermore, MEG3 contributes to the pathogenesis of HIC. Therefore, exosomal MEG3 in urine can be used as a biomarker for HIC diagnosis.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Hunner-type interstitial cystitis (HIC); MEG3; TLR7; biomarker; exosome; long noncoding RNA; miR-19a-3p

Mesh:

Substances:

Year:  2019        PMID: 31595563     DOI: 10.1002/jcb.29356

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Extracellular vesicles enhance oxidative stress through P38/NF-kB pathway in ketamine-induced ulcerative cystitis.

Authors:  Xiao Jian Xi; Jin Jiang Zeng; Yong Lu; Shao Hua Chen; Zhi Wen Jiang; Peng Jie He; Hua Mi
Journal:  J Cell Mol Med       Date:  2020-05-22       Impact factor: 5.310

2.  Decreased Excretion of Urinary Exosomal Aquaporin-2 in a Puromycin Aminonucleoside-Induced Nephrotic Syndrome Model.

Authors:  Ahmed Abdeen; Hiroko Sonoda; Ayaha Kaito; Sayaka Oshikawa-Hori; Naruki Fujimoto; Masahiro Ikeda
Journal:  Int J Mol Sci       Date:  2020-06-16       Impact factor: 5.923

Review 3.  Exosomal Long Non-Coding RNAs in Lung Diseases.

Authors:  Christophe Poulet; Makon-Sébastien Njock; Catherine Moermans; Edouard Louis; Renaud Louis; Michel Malaise; Julien Guiot
Journal:  Int J Mol Sci       Date:  2020-05-19       Impact factor: 5.923

4.  Mechanism of M2 macrophage-derived extracellular vesicles carrying lncRNA MEG3 in inflammatory responses in ulcerative colitis.

Authors:  Yu-Xuan Wang; Cheng Lin; Lu-Jia Cui; Tao-Zhi Deng; Qiu-Min Li; Feng-Ying Chen; Xin-Pu Miao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

5.  Urinary extracellular vesicle microRNA profiling for detection in patients with interstitial cystitis.

Authors:  Fumihiko Urabe; Akira Furuta; Taro Igarashi; Yasuyuki Suzuki; Shin Egawa; Takahiro Kimura
Journal:  Transl Androl Urol       Date:  2022-07

Review 6.  Biomarkers in the Light of the Etiopathology of IC/BPS.

Authors:  Jochen Neuhaus; Mandy Berndt-Paetz; Andreas Gonsior
Journal:  Diagnostics (Basel)       Date:  2021-11-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.